AP LifeSciences is a biotechnology company that specializes in the diagnostic and treatment of kidney stone disease. The firm's first product, Oxalate Diptick, uses patented technology to monitor oxalate levels in urine and blood. The test is quick and can be easily done at home or at a physicianâs office, therefore saving the patientsâ time and money. The mission is to enable patients to take an active role in maintaining their health with easy-to-use one-step tests. AP LifeSciences is a structured Delaware corporation, with contributing founding members coming from scientific, financial and entrepreneurial backgrounds. It utilizes the advice and expertise of medical doctors throughout the development and launching of Oxalate dipstick technology. The diverse team covers different areas from the production technology to the launching and marketing of products within the United States and beyon
